E-LIB Suche - Ergebnisse für: Zonder, Jeffrey

1

Safety And Tolerability Of Cael-101, An Anti-amyloid Monocl..:

Valent, Jason ; Liedtke, Michaela ; Zonder, Jeffrey...
Journal of Cardiac Failure. 30 (2024) 1 - p. 233 , 2024

Link: https://doi.org/10.1016/..

2

INSURE: a pooled analysis of ixazomib-lenalidomide-dexameth..:

Leleu, Xavier ; Lee, Hans C ; Zonder, Jeffrey A...
Future Oncology. 20 (2024) 14 - p. 935-950 , 2024

Link: https://doi.org/10.2217/..

3

Real-world multiple myeloma risk factors and outcomes by no..:

Buck, Tondre ; Hartley-Brown, Monique A. ; Efebera, Yvonne A....
Haematologica. , 2023

Link: https://doi.org/10.3324/..

4

A phase I study of selinexor combined with weekly carfilzom..:

Derman, Benjamin A ; Chari, Ajai ; Zonder, Jeffrey...
European Journal of Haematology. 110 (2023) 5 - p. 564-570 , 2023

Link: https://doi.org/10.1111/..

5

Phase 1/2 study of carfilzomib, pomalidomide, and dexametha..:

Derman, Benjamin A. ; Zonder, Jeffrey ; Reece, Donna...
Blood Advances. 7 (2023) 19 - p. 5703-5712 , 2023

Link: https://doi.org/10.1182/..

6

Rates of Influenza and Pneumococcal Vaccination and Correla..:

Thompson, Michael A. ; Boccadoro, Mario ; Leleu, Xavier...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 3 - p. e171-e181 , 2023

Link: https://doi.org/10.1016/..

7

Birtamimab plus standard of care in light-chain amyloidosis..:

Gertz, Morie A. ; Cohen, Adam D. ; Comenzo, Raymond L....
Blood. 142 (2023) 14 - p. 1208-1218 , 2023

Link: https://doi.org/10.1182/..

8

S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENT..:

Lee, Hans C. ; Bumma, Naresh ; Richter, Joshua...
HemaSphere. 7 (2023) S3 - p. e1610068 , 2023

Link: https://doi.org/10.1097/..

9

Multivariable Analyses of Prognostic Factors for Progressio..:

Hassoun, Hani ; Jacobus, Susanna J ; Richardson, Paul G....
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S396-S397 , 2023

Link: https://doi.org/10.1016/..

10

S204: SAFETY AND TOLERABILITY OF CAEL-101, AN ANTI-AMYLOID ..:

Valent, Jason ; Liedtke, Michaela ; Zonder, Jeffrey...
HemaSphere. 7 (2023) S3 - p. e2801725 , 2023

Link: https://doi.org/10.1097/..

11

P-247 Efficacy and safety of linvoseltamab 200 mg in patien..:

Dhodapkar, Madhav ; Bumma, Naresh ; Richter, Joshua...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S172 , 2023

Link: https://doi.org/10.1016/..

12

OAB-056: Early, deep, and durable responses, and low rates ..:

Zonder, Jeffrey ; Richter, Joshua ; Bumma, Naresh...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S35 , 2022

Link: https://doi.org/10.1016/..

13

P-268: INSURE: a global pooled analysis of patients (pts) w..:

Ramasamy, Karthik ; Hulin, Cyrille ; Leleu, Xavier...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S185 , 2022

Link: https://doi.org/10.1016/..

14

OAB-047: Clinical and translational results of the myeloma ..:

Kumar, Shaji ; Jayasinghe, Reyka ; Bianchi, Giada...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S29 , 2022

Link: https://doi.org/10.1016/..

15

Preferences and Priorities for Relapsed Multiple Myeloma Tr..:

Auclair, Daniel ; Mansfield, Carol ; Fiala, Mark A...
Patient Preference and Adherence. 16 (2022) - p. 573-585 , 2022

Link: https://doi.org/10.2147/..